Wilmington Trust National Association’s Novo Nordisk NVO Stock Holding History

Wilmington Trust National Association’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.08M	Buy	46,650 +292	+0.6%	+$6.45K	0.04%	252
2014 Q1	$1.06M	Buy	46,358 +1,088	+2%	+$23.2K	0.04%	235
2013 Q4	$836K	Sell	45,270 -60	-0.1%	-$1.05K	0.03%	266
2013 Q3	$768K	Buy	45,330 +1,060	+2%	+$17.8K	0.03%	272
2013 Q2	$686K	Buy	+44,270	New	+$737K	0.03%	273

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Wilmington Trust National Association's NVO Position: Q2 2014 in Review

Wilmington Trust National Association increased its Novo Nordisk (NVO) stake by 0.63% in Q2 2014, buying an estimated $6.45K and bringing the position to 46,650 shares worth $1.08M. The position accounts for 0.04% of the portfolio, ranked #252.

Wilmington Trust National Association first reported a position in NVO in Q2 2013 and has held it in 5 quarters since. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

Wilmington Trust National Association held 46,650 shares of Novo Nordisk worth $1.08M as of Q2 2014.
Wilmington Trust National Association bought 292 Novo Nordisk shares in Q2 2014, an estimated $6.45K.
Novo Nordisk made up 0.04% of Wilmington Trust National Association's portfolio in Q2 2014, its #252 holding.
Wilmington Trust National Association first reported a position in Novo Nordisk in Q2 2013 and has held it in 5 quarters since.
473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.